EDIT Short Volume
Editas Medicine, Inc. (EDIT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $349.5M, listed on NASDAQ, employing roughly 246 people, carrying a beta of 2.14 to the broader market. Editas Medicine, Inc. Led by Gilmore O'Neill, public since 2016-02-03.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 1.0M
- Total Volume
- 1.5M
- Short %
- 68.14%
- 30-Day Avg Short %
- 37.64%
Showing 30 days of FINRA short volume data for Editas Medicine, Inc..
Learn how short volume is reported and how to read the data →
Frequently asked EDIT short volume questions
- What is the daily EDIT short volume?
- As of Jun 1, 2026, Editas Medicine, Inc. (EDIT) short volume is 1.0M shares against 1.5M total reported volume, or 68.14% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is EDIT short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does EDIT short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.